SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sézary cells

Journal of Immunology

Volumn 176, Issue 1, 2006, Pages 652-659

  Huet, Delphine ^a   Bagot, Martine ^a   Loyaux, Denis ^b   Capdevielle, Joël ^b   Conraux, Laurence ^b   Ferrara, Pascual ^b   Bensussan, Armand ^a,c   Marie Cardine, Anne ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b SANOFI   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MONOCLONAL ANTIBODY; RNA; VIMENTIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LYMPHOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEZARY CELL; SKIN LYMPHOMA; SKIN TUMOR; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 29644442799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.1.652     Document Type: Article

References (37)

1. Willemze, R., H. Kerl, W. Sterry, E. Berti, L. Cerroni, S. Chimenti, J. L. Diaz-Perez, M. L. Geerts, M. Goos, R. Knobler, et al. 1997. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90: 354-371.
2. Rook, A. H., S. L. Gottlieb, J. T. Wolfe, B. R. Vowels, S. S. Sood, Z. Niu, S. R. Lessin, and F. E. Fox. 1997. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin. Exp. Immunol. 107(Suppl. 1): 16-20.
3. Van Doorn, R., R. Dijkman, M. H. Vermeer, J. J. Out-Luiting, E. M. van der Raaij-Helmer, R. Willemze, and C. P. Tensen. 2004. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res. 64: 5578-5586.
4. Mao, X., G. Orchard, D. M. Lillington, R. Russell-Jones, B. D. Young, and S. J. Whittaker. 2003. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101: 1513-1519.
5. Mao, X., G. Orchard, D. M. Lillington, F. J. Child, E. C. Vonderheid, P. C. Nowell, M. Bagot, A. Bensussan, R. Russell-Jones, B. D. Young, and S. J. Whittaker. 2004. BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br. J. Dermatol. 151: 546-556.
6. Su, M. W., I. Dorocicz, W. H. Dragowska, V. Ho, G. Li, N. Voss, R. Gascoyne, and Y. Zhou. 2003. Aberrant expression of T-plastin in Sezary cells. Cancer Res. 63: 7122-7127.
7. - T lymphocyte subsets in Sezary syndrome. Arch. Dermatol. Res. 291: 307-311.
8. Jones, D., N. H. Dang, M. Duvic, L. T. Washington, and Y. O. Huh. 2001. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am. J. Clin. Pathol. 115: 885-892.
9. - T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome. J. Am. Acad. Dermatol. 44: 456-461.
10. Vonderheid, E. C., R. D. Bigler, A. Kotecha, C. M. Boselli, S. R. Lessin, M. G. Bernengo, and M. Polansky. 2001. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome). J. Invest. Dermatol. 117: 654-662.
11. Yagi, H., Y. Tokura, F. Furukawa, and M. Takigawa. 1996. CD7-positive Sezary syndrome with a Th1 cytokine profile. J. Am. Acad. Dermatol. 34: 368-374.
12. - subset in the identification of circulating Sezary cells. Br. J. Dermatol. 144: 125-135.
13. + cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 97: 1388-1391.
14. Poszepczynska-Guigne, E., V. Schiavon, M. D'Incan, H. Echchakir, P. Musette, N. Ortonne, L. Boumsell, A. Moretta, A. Bensussan, and M. Bagot. 2004. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J. Invest. Dermatol. 122: 820-823.
15. Wechsler, J., M. Bagot, M. Nikolova, S. Parolini, N. Martin-Garcia, L. Boumsell, A. Moretta, and A. Bensussan. 2003. Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes. J. Pathol. 199: 77-83.
16. Nikolova, M., M. Bagot, L. Boumsell, and A. Bensussan. 2002. Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas. Leuk. Lymphoma 43: 741-746.
17. Nikolova, M., A. Tawab, A. Marie-Cardine, M. Bagot, L. Boumsell, and A. Bensussan. 2001. Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. J. Invest. Dermatol. 116: 731-738.
18. Linsley, P. S., J. Bradshaw, J. Greene, R. Peach, K. L. Bennett, and R. S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535-543.
19. Linsley, P. S., and P. Golstein. 1996. Lymphocyte activation: T-cell regulation by CTLA-4. Curr. Biol. 6: 398-400.
20. Goyert, S. 1987. CD68 workshop panel report. In Leukocyte Typing VI. Garland Publishing, New York, pp. 1015-1016.
21. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
22. fyn protein tyrosine kinase. Eur. J. Immunol. 25: 3290-3297.
23. Da Silva, A. J., Z. Li, C. de Vera, E. Canto, P. Findell, and C. E. Rudd. 1997. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc. Natl. Acad. Sci. USA 94: 7493-7498.
24. Davison, M. D., and D. R. Critchley. 1988. α-Actinins and the DMD protein contain spectrin-like repeats. Cell 52: 159-160.
25. 2+-binding protein is not expressed in transformed T lymphocyte lines. J. Immunol. 141: 3999-4004.
26. Mor-Vaknin, N., A. Punturieri, K. Sitwala, and D. M. Markovitz. 2003. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5: 59-63.
27. Xu, B., R. M. de Wall, N. Mor-Vaknin, C. Hibbard, D. M. Markovitz, and M. L. Kahn. 2004. The endothelial cell-specific anitbody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell. Biol. 24: 9198-9206.
28. Ades, E. W., F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse, and T. J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99: 683-690.
29. Page, C., M. Rose, M. Yacoub, and R. Pigott. 1992. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141: 673-683.
30. Schlingemann, R. O., G. M. Dingjan, J. J. Emeis, J. Blok, S. O. Warnaar, and D. J. Ruiter. 1985. Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 52: 71-76.
31. Martin, S. J., D. R. Green, and T. G. Cotter. 1994. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem. Sci. 19: 26-30.
32. Brockstedt, E., A. Rickers, S. Kostka, A. Laubersheimer, B. Dorken, B. Wittmann-Liebold, K. Bommert, and A. Otto. 1998. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line: cleavage of heterogeneous nuclear ribonucleoprotein Al by caspase 3. J. Biol. Chem. 273: 28057-28064.
33. Scanlan, M. J., I. Gout, C. M. Gordon, B. Williamson, E. Stockert, A. O. Gure, D. Jager, Y. T. Chen, A. Mackay, M. J. O'Hare, and L. J. Old. 2001. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun. 1: 4.
34. Old, L. J. 2001. Cancer/testis (CT) antigens: a new link between gametogenesis and cancer. Cancer Immun. 1: 1.
35. Hartmann, T. B., D. Thiel, R. Dummer, D. Schadendorf, and S. Eichmuller. 2004. SEREX Identification of new tumor-associated antigens in cutaneous T-cell lymphoma. Br. J. Dermatol. 150: 252-258.
36. Lang, S. H., C. Hyde, I. N. Reid, I. S. Hitchcock, C. A. Hart, A. A. Bryden, J. M. Villette, M. J. Stower, and N. J. Maitland. 2002. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263.
37. Papadopoulos, N., A. Kotini, A. Cheva, T. Jivannakis, M. Lambropoulou, M. Bobos, S. Vavetsis, and D. Tamiolakis. 2002. Immunohistochemical expression of vimentin and secretory component antigens in endometrial hyperplasia and neoplasia. Eur. J. Gynaecol. Oncol. 23: 411-414.